Compugen (CGEN) Other Operating Expenses (2009 - 2026)
Compugen (CGEN) reported Other Operating Expenses of $134000.0 for Q1 2026, down 3.6% on a YoY basis from $139000.0 in Q1 2025, and up 11.67% sequentially from $120000.0 in Q4 2025.
Compugen (CGEN) Other Operating Expenses (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of Other Operating Expenses data on file, last reported at $134000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses fell 3.6% year-over-year to $134000.0; the trailing twelve-month figure through Mar 2026 stood at $534000.0 (down 14.42% YoY), and the FY2025 full-year result was $539000.0, down 6.42% from the prior year.
- Other Operating Expenses climbed to $134000.0 in Q1 2026, from $120000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $263000.0 in Q3 2022 to a low of $18000.0 in Q3 2023.
- A 5-year average of $142647.1 and a median of $139000.0 in 2025 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses plunged 93.16% in 2023 and soared 794.44% in 2024, its largest moves.
- Tracing CGEN's Other Operating Expenses over 5 years: stood at $191000.0 in 2022, then tumbled by 68.06% to $61000.0 in 2023, then jumped by 173.77% to $167000.0 in 2024, then retreated by 28.14% to $120000.0 in 2025, then grew by 11.67% to $134000.0 in 2026.
- Business Quant data shows CGEN's Other Operating Expenses at $134000.0 in Q1 2026, $120000.0 in Q4 2025, and $139000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 141,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 167,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 157,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 61,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Mar 31, 2023 | 116,000.00 |
| Dec 31, 2022 | 191,000.00 |
| Sep 30, 2022 | 263,000.00 |
| Jun 30, 2022 | 255,000.00 |
| Mar 31, 2022 | 223,000.00 |
| Dec 31, 2021 | 211,000.00 |
| Sep 30, 2021 | 166,000.00 |
| Jun 30, 2021 | 241,000.00 |